Texas invests $50M in psychedelic drug research to treat addiction
Medical Xpress
JUNE 16, 2025
The law directs Texas universities and hospitals to lead the research. Ibogaine shows potential for promoting neuroplasticity and aiding recovery, though it carries cardiac risks that require careful management. It also makes sure the state keeps a share in future profits if the drug is approved.
Let's personalize your content